Cell
Volume 15, Issue 1, September 1978, Pages 283-298
Journal home page for Cell

A possible mammary stem cell line

https://doi.org/10.1016/0092-8674(78)90104-6Get rights and content

Abstract

The cell line Rama 25 is derived from a mammary tumor induced in a rat by dimethylbenzanthracene. During rapid proliferation, Rama 25 cells appear as a single undifferentiated epithelial type; at high cell densities, however, small numbers of two other cell types are formed, which respectively resemble secretory and myoepithelial cells of the mammary gland, as judged by light and electron microscopy and immunofluorescent staining for casein (milk proteins). These additional cell types cannot be explained as contaminating cell populations since the cell line has been cloned several times; furthermore, the proportion of either can be increased by dimethylsulphoxide under different conditions. Specific epithelial features are seen by histological and ultrastructural examination of tumors formed by Rama 25 cells in immunodeficient mice. A line of the myoepithelial-like cells, Rama 29, isolated from a Rama 25 culture by cloning, is also described.

We propose that the undifferentiated cell type is a form of mammary stem cell which can differentiate in culture.

References (54)

  • K.E. Ebner et al.

    Exp. Cell Res.

    (1961)
  • M.K. Feldman et al.

    Comp. Biochem. Physiol.

    (1970)
  • P.R. Kerkof et al.
  • C. Palfrey et al.

    Biochem. Biophys. Res. Commun.

    (1977)
  • J.G. Rheinwald et al.

    Cell

    (1975)
  • G. Slemmer

    J. Invest. Dermatol.

    (1974)
  • R.W. Turkington et al.

    Biochim. Biophys. Acta

    (1967)
  • W. Bloom et al.
  • J.S. Butel et al.

    Cancer Res.

    (1977)
  • L.A. Cohen et al.

    In Vitro

    (1974)
  • E.W. Dempsey et al.

    Am. J. Anat.

    (1947)
  • R.W. Evans

    Histological Appearances of Tumours

    (1958)
  • J.T. Emerman et al.
  • D.W. Fawcett

    An Atlas of Fine Structure

  • M.K. Feldman et al.

    Histochem. J.

    (1975)
  • L.M. Franks et al.

    Int. J. Cancer

    (1972)
  • L.M. Franks et al.

    Cancer Res.

    (1976)
  • C. Friend et al.
  • A.J. Hackett et al.

    J. Nat. Cancer Inst.

    (1977)
  • R.C. Hallowes et al.

    J. Endocrinol.

    (1973)
  • R.C. Hallowes et al.

    Cancer Res.

    (1977)
  • K.H. Hollman
  • H.L. Hosick

    Cancer Res.

    (1974)
  • C. Huggins et al.

    Nature

    (1961)
  • M.A. Knowles et al.

    Cancer Res.

    (1977)
  • J.P. Kraehenbuhl

    J. Cell Biol.

    (1977)
  • U.K. Laemmli

    Nature

    (1970)
  • Cited by (188)

    • Tumor heterogeneity

      2017, Patient Derived Tumor Xenograft Models: Promise, Potential and Practice
    • Hormonal Control of Breast Development

      2015, Endocrinology: Adult and Pediatric
    • Evolution of the cancer stem cell model

      2014, Cell Stem Cell
      Citation Excerpt :

      Studies to answer these questions require functional assays. Although the idea that cancer retains features of embryological development has a long history (Cohnheim, 1875), the modern idea that developmental programs underlying normal tissue organization may still function to some extent in cancer began with seminal studies of teratocarcinoma (Pierce et al., 1960), small cell lung carcinoma (Baylin et al., 1978), and mammary carcinoma (Bennett et al., 1978; Hager et al., 1981). They suggested that many tumor cells were differentiated and that these “differentiated” cells were generated by tumor “stem” cells, similar to normal tissue stem cells producing normally differentiated tissues.

    • Statistical association of basal cell keratins with metastasis-inducing proteins in a prognostically unfavorable group of sporadic breast cancers

      2011, American Journal of Pathology
      Citation Excerpt :

      In addition to the complex of cytokeratins that include CK5/6 and CK14 being found in basally situated smooth muscle actin/myosin-containing myoepithelial cells,6 they are also detected in occasional suprabasal epithelial cells, particularly in growing terminal ductal structures.31,51–53 The observations of intermediate cell forms between the more peripheral cells in these structures and the subtending epithelial and myoepithelial cells52,54,55 are in line with findings in cultured human breast epithelial cells56,57 that a subclass of epithelial-like cells containing basal cell cytokeratins54,55,58 progressively differentiates into myoepithelial or into luminal epithelial cells, as reported originally in rodent systems.59–61 Thus, the basal-like breast carcinomas may contain the vestiges of a normal breast stem cell that has lost its capability to differentiate completely into end-stage myoepithelial cells,58,62,63 but still expresses basal cell cytokeratins,64 as well as CK19,65,66 vimentin,67 CD44,68 ALDH1,69 and/or CD133.70

    • Interaction in vivo and in vitro of the metastasis-inducing S100 protein, S100A4 (p9Ka) with S100A1

      2000, Journal of Biological Chemistry
      Citation Excerpt :

      The heterodimerization of S100A1 and S100A4 reported here might be expected to have biological significance if these S100 proteins occur in the same cells. These proteins have been shown to coexist in the same cultured human breast cancer cells and in rat mammary cells, Rama 29 (not shown) (30), and coexpression of S100A1 and S100A4 has been reported previously in primary cultures and cell lines of human vascular smooth muscle cells (14). In the present experiments, S100A1 and S100A4 are both located in the perinuclear region and on the stress fibers of the cytoskeleton.

    View all citing articles on Scopus
    View full text